AI filing briefs · archive

8-K filings in June 2025, explained

441 material Form 8-K filings that 376 companies we cover made with the SEC in June 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

2 of 441 briefs match

newest first · times in ET

DCIDONALDSON Co INC Jun 2, 5:35 PM ET

Donaldson Q3 sales rise 1.3% as GAAP earnings fall 49% on $62.0 million impairment

Mixed earnings Written later 2.02 5.02 7.01

Donaldson reported fiscal third-quarter 2025 results for the quarter ended April 30, 2025, with net sales up 1.3% to $940.1 million and GAAP net earnings down 49.1% to $57.8 million after a $62.0 million impairment of intangible assets. Adjusted diluted EPS rose 7.6% to $0.99, and the company narrowed its fiscal 2025 adjusted EPS guidance to $3.64 to $3.70, with the midpoint $0.03 above prior guidance. The company also named Richard B. Lewis as chief operating officer, effective August 1, 2025.

Net sales were $940.1 million, up 1.3%; GAAP diluted EPS was $0.48 versus $0.92 a year earlier.
The $62.0 million impairment includes $46.6 million for Univercells Technologies and $15.4 million for Solaris.
Adjusted diluted EPS was $0.99, up 7.6%; fiscal 2025 adjusted EPS guidance is $3.64 to $3.70.
Richard B. Lewis, currently president of Life Sciences, becomes COO on August 1, 2025, with fiscal 2026 base salary set at $750,000.

Read the filing on SEC.gov ↗

CPBCAMPBELL'S Co Jun 2, 7:16 AM ET

Campbell's Q3 sales up 4% to $2.5 billion; GAAP EPS down 50% on impairment

Mixed earnings Written later 2.02

Campbell's reported third-quarter fiscal 2025 results for the quarter ended April 27, 2025. Net sales rose 4% to $2.5 billion, but GAAP diluted EPS fell 50% to $0.22 after a $150 million non-cash impairment charge on the Snyder's of Hanover trademark. The company reaffirmed its full-year guidance but said adjusted EPS is now expected at the low end of the $2.95 to $3.05 range, and tariffs could add up to $0.03 to $0.05 per share in headwinds.

Net sales rose 4% to $2.5 billion, while organic net sales rose 1%; adjusted EBIT rose 2% to $362 million.
GAAP EPS was $0.22 versus $0.44; adjusted EPS fell 3% to $0.73 from $0.75.
Full-year fiscal 2025 adjusted EPS guidance of $2.95 to $3.05 was reaffirmed, now expected at the low end due to a slower Snacks recovery.
Snacks organic net sales fell 5%, and segment operating earnings fell 13%.

Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.